Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-23-210818
Filing Date
2023-08-11
Accepted
2023-08-11 16:38:36
Documents
9
Period of Report
2023-08-11

Document Format Files

Seq Description Document Type Size
1 PREM14A d536160dprem14a.htm PREM14A 1857907
2 EX-FILING FEES d536160dexfilingfees.htm EX-FILING FEES 22740
3 GRAPHIC g536160dsp1a.jpg GRAPHIC 1522
4 GRAPHIC g536160dsp1b.jpg GRAPHIC 1224
5 GRAPHIC g536160dsp1c.jpg GRAPHIC 2221
6 GRAPHIC g536160dsp1d.jpg GRAPHIC 1883
7 GRAPHIC g536160dsp2.jpg GRAPHIC 1898
8 GRAPHIC g536160dspp01.jpg GRAPHIC 8613
9 GRAPHIC g536160g02a02.jpg GRAPHIC 73746
  Complete submission text file 0001193125-23-210818.txt   2008131
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-37785 | Film No.: 231164720
SIC: 2834 Pharmaceutical Preparations